BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 28595206)

  • 21. Self-expanding platinum-coated nitinol devices for transcatheter closure of atrial septal defect: prevention of nickel release.
    Lertsapcharoen P; Khongphatthanayothin A; Srimahachota S; Leelanukrom R
    J Invasive Cardiol; 2008 Jun; 20(6):279-83. PubMed ID: 18523320
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transcatheter closure as an alternative and equivalent method to the surgical treatment of atrial septal defect in adults: comparison of early and late results.
    Suchon E; Pieculewicz M; Tracz W; Przewlocki T; Sadowski J; Podolec P
    Med Sci Monit; 2009 Dec; 15(12):CR612-7. PubMed ID: 19946231
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Displacement of Amplatzer septal occluder in a patient with atrial septal defects and an atrial septal aneurysm.
    Oda T; Kato S; Suda K
    Cardiol Young; 2016 Oct; 26(7):1430-1. PubMed ID: 27434107
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the Occlutech ® Figulla ® septal occluder and Amplatzer ® septal occluder for atrial septal defect device closure.
    Roymanee S; Promphan W; Tonklang N; Wongwaitaweewong K
    Pediatr Cardiol; 2015 Jun; 36(5):935-41. PubMed ID: 25633819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safe Surgical Retrieval of Embolized Atrial Septal Defect Closure Device.
    Yates MT; Anderson DR
    Ann Thorac Surg; 2017 Feb; 103(2):e213-e214. PubMed ID: 28109396
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of a parylene-coated occluder for atrial septal defect: a prospective, multi-center, randomized controlled clinical trial.
    Yang K; Lyu JH; Hu HB; Wu WH; Zhang GJ; Jin JL; Liu YH; Feng Y; Wang LM; Zhao SH; Jiang SL; Li W; Pan XB
    Chin Med J (Engl); 2021 Nov; 134(22):2685-2691. PubMed ID: 34759229
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coronary Sinus Defect Following Transcatheter Closure of ASD Using Amplatzer Septal Occluder: Potential Erosion by the Device.
    Mohammad Nijres B; Al-Kubaisi M; Bokowski J; Abdulla RI; Awad S
    Pediatr Cardiol; 2017 Jun; 38(5):1084-1086. PubMed ID: 28396933
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Percutaneous closure of patent foramen ovale with Atriasept II device in nickel allergic patients.
    Cammalleri V; Ussia GP; Marchei M; Muscoli S; Sergi D; Macrini M; Romeo F
    J Cardiovasc Med (Hagerstown); 2014 Apr; 15(4):350-2. PubMed ID: 24685961
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparative study of Cardi-O-Fix septal occluder versus Amplatzer septal occluder in percutaneous closure of secundum atrial septal defects.
    Saritas T; Kaya MG; Lam YY; Erdem A; Akdeniz C; Demir F; Erol N; Demir H; Celebi A
    Catheter Cardiovasc Interv; 2013 Jul; 82(1):116-21. PubMed ID: 21805616
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Percutaneous management of coronary sinus atrial septal defect: two cases representing the spectrum for device closure and a review of the literature.
    Sandeep N; Slack MC
    Cardiol Young; 2014 Oct; 24(5):797-806. PubMed ID: 24666783
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Percutaneous retrieval of a dislodged Amplatzer septal occluder device from the pulmonary artery with sole use of a snare and device lassoing.
    Manolis AS
    Hellenic J Cardiol; 2018; 59(1):57-59. PubMed ID: 28818637
    [No Abstract]   [Full Text] [Related]  

  • 32. Delayed spontaneous perforation of polyvinyl alcohol membrane-Covered atrial septal defect closure devices.
    Labombarda F; Roule V; Beygui F
    Catheter Cardiovasc Interv; 2017 Mar; 89(4):E141-E144. PubMed ID: 27535818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors of Atrial Septal Defect Occluder Dislodgement.
    Lee WC; Fang CY; Huang CF; Lin YJ; Wu CJ; Fang HY
    Int Heart J; 2015; 56(4):428-31. PubMed ID: 26118595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Device size for transcatheter closure of ovoid interatrial septal defect.
    Cho EH; Song J; Choi EY; Lee SY
    Heart Surg Forum; 2013 Aug; 16(4):E193-7. PubMed ID: 23958530
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Late systemic desaturation after transcatheter device closure of atrial septal defect.
    Bagaria V; Hiremath CS
    Cardiol Young; 2023 Jul; 33(7):1223-1225. PubMed ID: 36533532
    [TBL] [Abstract][Full Text] [Related]  

  • 36. I'll bet you a nickel you don't ask.
    Block PC
    J Invasive Cardiol; 2015 Feb; 27(2):105. PubMed ID: 25661762
    [No Abstract]   [Full Text] [Related]  

  • 37. Very late cardiac tamponade following successful transcatheter closure of an atrial septal defect with the Amplatzer septal occluder.
    Herren T; Schwanda M; Genoni M; Eberli FR
    Clin Res Cardiol; 2015 Jun; 104(6):530-3. PubMed ID: 25720331
    [No Abstract]   [Full Text] [Related]  

  • 38. Percutaneous atrial septal occluder devices and cardiac erosion: a review of the literature.
    Crawford GB; Brindis RG; Krucoff MW; Mansalis BP; Carroll JD
    Catheter Cardiovasc Interv; 2012 Aug; 80(2):157-67. PubMed ID: 22552868
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cobrahead Deformity in the Right Atrial Disc of a New-Generation Occlutech Figulla Flex II Atrial Septal Defect Occluder Device.
    Kilic T; Ural E; Sahin T
    Tex Heart Inst J; 2015 Oct; 42(5):454-7. PubMed ID: 26504440
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Percutaneous closure of three atrial septal defects with three interleaved atrial septal occluders in an adult patient.
    Nerlekar N; Narayan O; Sapontis J; Stokes M; Vasanthakumar SA; Mottram PM; Harper RW
    Int J Cardiol; 2016 Apr; 209():7-8. PubMed ID: 26874451
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.